SCP
Overview
SeaLink Capital Partners (SCP) is a private equity firm based in Mumbai, India, founded in 2015. The firm focuses on partnering with and making long-term, value-oriented investments in mid-sized Indian companies with strong growth potential. SCP targets sectors such as healthcare, information technology, financial services, business services, consumer products, and niche manufacturing. The firm employs an active ownership model, working closely with entrepreneurs and management teams to drive growth and operational improvements. The investment in THB (Sekhmet Technologies) in 2021, a clinical intelligence company, is a confirmed part of their portfolio.
Portfolio Companies
2
Website
sealinkcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NephroPlus | Dec 2021 | Series E | - |
| dYdX | Jan 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SCP based?
SCP is headquartered in Mumbai, Maharashtra, India.
When was SCP founded?
Founding year information for SCP is not publicly available.
How many portfolio companies does SCP have?
SCP has 2 portfolio companies in Caplight's dataset.
What are some companies in SCP's portfolio?
Portfolio companies visible on Caplight include NephroPlus, dYdX.
What was SCP's most recent investment shown here?
SCP's most recent investment in this portfolio sample was in NephroPlus in 2021.
What sectors does SCP focus on?
SCP focuses on Healthcare & Life Sciences, Crypto & Web3, FinTech.
What company stages does SCP focus on?
SCP typically invests at the Mid stage.
What is SCP's AUM?
SCP's assets under management are estimated at over $315.0M.